Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Maciej Banach

21 ta ish

University of Washington

AkademScholarda batafsil koʻrsatkichlar

  1. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

    Leandra Abarca-Gómez, Ziad Abdeen, Zargar Abdul Hamid +97

    MaqolaOchiq kirish20177 iqtibos
    ABI

  2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Sadaf G Sepanlou, Saeid Safiri, Catherine Bisignano +97

    MaqolaOchiq kirish20206 iqtibos
    ABI

  3. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Boris Bikbov, Caroline Purcell, Andrew S. Levey +97

    Maqola20206 iqtibos
    ABI

  4. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons +97

    MaqolaOchiq kirish20215 iqtibos
    ABI

  5. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

    Rachel Black, Marita Cross, Lydia M Haile +97

    MaqolaOchiq kirish20235 iqtibos
    ABI

  6. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

    Marissa B Reitsma, Parkes Kendrick, Emad Ababneh +97

    MaqolaOchiq kirishSmoking Behavior and CessationThe Lancet20214 iqtibos
    ABI

  7. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

    Antonio J. Vallejo‐Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai +69

    MaqolaOchiq kirish20163 iqtibos
    ABI

  8. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

    Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei +97

    MaqolaOchiq kirish20213 iqtibos
    ABI

  9. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

    Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens +97

    MaqolaOchiq kirish20233 iqtibos
    ABI

  10. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

    Khadijeh Koushki, Sanaz Keshavarz Shahbaz, Kazem Mashayekhi +7

    Sharh maqola20203 iqtibos
    ABI

  11. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Valery L. Feigin, Emma Nichols, Shazia Alam +97

    Maqola20193 iqtibos
    ABI

  12. Statin use and risk of diabetes mellitus in postmenopausal women

    Niki Katsiki, Maciej Banach

    Maqola20123 iqtibos
    ABI

  13. EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

    Kausik K. Ray, Bart Molemans, W. Marieke Schoonen +28

    Maqola20203 iqtibos
    ABI

  14. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    Haidong Wang, Kaja Abbas, Mitra Abbasifard +97

    MaqolaOchiq kirishGlobal Maternal and Child HealthThe Lancet20202 iqtibos
    ABI

  15. Familial hypercholesterolaemia: A global call to arms

    Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole +44

    MaqolaOchiq kirish20152 iqtibos
    ABI

  16. Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

    Sonu Bhaskar, Akansha Sinha, Maciej Banach +6

    MaqolaOchiq kirish20202 iqtibos
    ABI

  17. PCSK9 and inflammation: a review of experimental and clinical evidence

    Amir Abbas Momtazi‐Borojeni, Sarvenaz Sabouri-Rad, Antonio M. Gotto +5

    Sharh maqolaOchiq kirish20192 iqtibos
    ABI

  18. Proprotein Convertase Subtilisin/Kexin Type 9

    Chiara Macchi, Nicola Ferri, Cesare R. Sirtori +3

    Sharh maqolaOchiq kirish20212 iqtibos
    ABI

  19. PCSK9 and diabetes: is there a link?

    Amir Abbas Momtazi, Maciej Banach, Matteo Pirro +2

    Sharh maqola20172 iqtibos
    ABI

  20. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Brittney S Sheena, Lindsey Hiebert, Hannah Han +97

    Maqola20222 iqtibos
    ABI

  21. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Rafael Lozano, Nancy Fullman, John Everett Mumford +97

    MaqolaOchiq kirishHealthcare Systems and ReformsThe Lancet20201 iqtibos
    ABI